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Background: This study describes the accuracy of three-dimensional power Doppler (3D-PD) angiography as
secondary method for differential diagnosis of ovarian tumors.
Method: Seventy-five women scheduled for surgical removal of adnexal masses were assessed by transvaginal
ultrasound. Ovarian tumors were classified by IOTA simple rules and two three-dimensional blocks were recorded.
In a second step analyses, a 4 cm3 spherical sample was obtained from the highest vascularized solid area of each
stored block. Vascularization index (VI), flow index (FI) and vascularization-flow index (VFI) were calculated. The
repeatability was assessed by concordance correlation coefficient (CCC) and limits of agreement (LoA), and diagnostic
accuracy by area under ROC curve.
Results: IOTA simple rules classified 26 cases as benign, nine as inconclusive and 40 as malignant. There were eight
false positive and no false negative. Among the masses classified as inconclusive or malignant by IOTA simple rules, the
CCCs were 0.91 for VI, 0.70 for FI, and 0.86 for VFI. The areas under ROC curve were 0.82 for VI, 0.67 for FI and 0.81 for VFI.
Conclusions: 3D-PD angiography presented considerable intraobserver variability and low accuracy for identifying false
positive results of IOTA simple rules.
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Ovarian cancer is the leading cause of death among
gynecological cancers [1]. Because the patient survival is
strongly associated with disease stage, there have been
many attempts of early diagnosis. While the occurrence
of masses in adnexal region is very frequent (up to
20 %), the prevalence of ovarian cancer is low (approxi-
mately 0.2-0.3 % in post-menopausal women). To detect
one ovarian cancer case using screening methods, ap-
proximately 5 women will be submitted to surgery [2, 3].
Tranvaginal ultrasonography is one of the most evalu-
ated methods for early detection of ovarian cancer. In
clinical practice, detected adnexal masses can be classi-
fied according to International Tumor Ovarian Analysis
(IOTA) “simple rules”. IOTA simple rules are based on* Correspondence: fjcreis@fmrp.usp.br
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ventional ultrasound examination and presents high sen-
sitivity [4]. However, the false positive rate is elevated.
About 40-50 % of the women with inconclusive and ma-
lignant results by IOTA simple rules have benign ovarian
tumors [5, 6].
Three-dimensional ultrasonography allows quantifying
blood flow and vascularization in ovarian tumors [7]. Vas-
cularization index (VI), flow index (FI) and vascularization-
flow index (VFI) can be calculated after manual outlining
of vascularized solid areas within the tumor [8] or after
spherical sampling from the most vascularized area of the
tumor, the area is selected by the examiner and the spher-
ical sampling performed automatically by the software [9].
The results are similar for both methods, however virtual
spherical sampling saves time compared with manual
sampling when the examiner is less experienced [10].
Differences in vascularization between malignant and
benign ovarian tumors are well established [11] andarticle distributed under the terms of the Creative Commons Attribution License
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Table 1 Final diagnosis of 75 adnexal masses
Histology N %
Benign
Brenner tumor 2 2.7
Dermoid cyst 8 10.7
Endometriotic cyst 11 14.7
Fibroma 4 5.3
Haemorragic cyst 3 4.0
Mucinous adenoma 8 10.7
Serous adenoma 6 8.0
Ovarian abscess sequelae 1 1.3
Malignant
Clear cell carcinoma 1 1.3
Endometrioid carcinoma 2 2.7
Metastatic tumor 5 6.7
Mucinous bordeline tumor 2 2.7
Serous borderline tumor 3 4.0
Serous carcinoma 13 17.3
Stromal tumor 4 5.3
Transitional cell carcinoma 1 1.3
Undifferentiated carcinoma 1 1.3
Table 2 IOTA and 3D-PD indices according to final diagnosis
Benign (N = 43) Malignant (N = 32) P
Agea 42 (18–82) 52 (20–78) 0.02




VIa 4.5 (0.01–28.8) 19.6 (3.4–55.9) <0.0001
FIa 38.1 (23.0–58.2) 47.3 (31.2–60.2) 0.0001
VFIa 1.7 (0.002–10.4) 9.1 (1.6–30.7) <0.0001
amedian (range), Mann–Whitney test
bFisher's exact test
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correlated with tissue perfusion as reported for experi-
mental models [12–14]. However, the usefulness of vas-
cular virtual biopsies for differential diagnosis of adnexal
masses is still controversy [15, 16]. In this study, our ob-
jective was to evaluate whether 3D-PD angiography can
be used to reduce the false positives among adnexal
masses with inconclusive or malignant result according
to IOTA simple rules.
Methods
Study design
We invited 75 women that were consecutively scheduled
for surgery to remove adnexal masses from September
2008 to December 2010. All these women accepted to
participate and were included in the study. The study
was approved by the institutional review board (Ethics
Committee of the University Hospital of Ribeirao Preto
School of Medicine) and informed consents were ob-
tained from all participants. Final diagnoses were based
on the tumor histology, classified according to WHO
criteria [17]. The manuscript was prepared following the
STARD (diagnostic accuracy studies) guideline.
Ultrasound
Participants were assessed by transvaginal ultrasound scan
using a Voluson 730 (GE Healthcare, Zipf, Austria) ultra-
sound machine equipped with a volumetric vaginal probe
(RIC5-9-D). The adnexal masses were classified as benign,
malignant or inconclusive according to IOTA simple rules
[18]. Briefly, if one or more malignant features were present
in absence of benign feature, the mass was classified as ma-
lignant; if one or more benign features were present in ab-
sence of malignant feature, the mass was classified as
benign; if both malignant features and benign features were
present, or if no benign or malignant feature was present,
the result was inconclusive. Vascular power Doppler score
is included in IOTA simple rules as one variable: a score of
1 is given when no blood flow is found in the tumor, a
score of 2 when only minimal flow is detected, a score of
three when moderate flow is present and a score of four
when the tumor presents marked blood flow [19].
After the conventional ultrasound, the same observer ac-
quired two three-dimensional volumes from the adnexal
masses. For large tumors, when it was not possible to com-
pletely include the tumor in the block, the sonographer
chose the most complex area of the tumor to be sampled
and attempted to sample the same area for both blocks.
The following predetermined power Doppler settings that
were kept constant throughout the study: (Main PD set-
tings) Filter = low1; PRF = 0.6 KHz; gain = 0.0; Quality =
normal; (Sub PD settings) Freq =mid; Flow res =mid1;
Smooth = 5/6; Ensemble = 12; Line Den = 7; PD map = 5
(Gently Color = on); Balance = G > 200; Artifact = on; L.Filter = 2. The blocks were recorded for later analyses. The
maximum interval time between ultrasound scan and sur-
gery was 7 days; this was performed to reduce the risk of
the occurrence/regression of a disease between the ultra-
sound scan and the surgery.
3D-PD angiography
A 4 cm3 spherical sample was obtained from the highest
vascularized solid area of each tumor stored block using
the 4D View software (version 5.0, GE Healthcare). The
maximum distance between the ultrasound probe and
the spherical sample was 4 cm (mean = 2 cm; average
difference between distances from each pair of samples =
0.1 cm; effect size of intra-pair variation = 0.04). VI, FI and
Table 3 Repeatability analyses of the 3D-PD indices in the 49
adnexal masses with inconclusive or malignant results by IOTA
simple rules: concordance correlation coefficient (CCC) and limits
of agreement (LoA)
CCC (95 % CI) Mean difference (LoA)
VI 0.91 (0.84 to 0.95) 0.12 (−10.6 to +10.9)
FI 0.70 (0.53 to 0.82) −0.02 (−13.1 to +13.0)
VFI 0.86 (0.77 to 0.92) 0.33 (−6.1 to + 6.8)
VI vascularization index, FI flow index, VFI vascularization-flow index
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histological result.Statistical analyses
Statistical analysis was conducted using STATA/SE ver-
sion 13 (StataCorp). Mann–Whitney test was used to
compare quantitative variables between benign and ma-
lignant groups, Fisher's exact test to analyze contingency
tables and Kruskal-Wallis test to compare the 3D-PD in-
dices among the tumors grouped by power DopplerFig. 1 Repeteability and accuracy of 3D-PD indices in ovarian tumors with
vascularization index (VI), b Bland and Altman plot for flow index (FI), c Bla
3D-PD indicesscores. Intra-observer repeatability and diagnostic accur-
acy and were evaluated for 49 women with inconclusive
or malignant results by IOTA. The intra-observer re-
peatability was assessed comparing the results of vascu-
lar virtual biopsies from the two blocks of each tumor
by the concordance correlation coefficient (CCC) [20]
and the limits of agreement (LoA) of the relative differ-
ence between measurements [21]. CCC values should be
higher than 0.70 to be used as research tool, higher than
0.90 to be used in clinical practice, and higher than 0.95
for individual and important decisions [22]. The diag-
nostic accuracy of 3D-PD indices was estimated by the
area under ROC curve.
Results
The final histology of adnexal masses is presented in the
Table 1, 32 (43 %) were malignant and 43 (57 %) benign.
According to IOTA simple rules, 26 adnexal masses
were classified as benign, 40 as malignant and 9 cases
had inconclusive result. IOTA simple rules presented
100 % of sensitivity and 60 % of specificity. IOTA simplemalignant or inconclusive IOTA results. a Bland and Altman plot for
nd and Altman plot for vascularization-flow index (VFI), d ROC curve for
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Table 2.
Intra-observer repeatabilities of 3D-PD indices from
virtual vascular biopsies in the group of 49 cases with
malignant or inconclusive results according to IOTA
classification are shown in Table 3. We would expect
that 95 % of the differences between pairs of measure-
ments would be less than 10.8 for VI, less than 13.0 for
FI and less than 6.4 for VFI (Fig. 1).
Diagnostic accuracies of 3D-PD indices for reclassi-
fyadnexal masses with inconclusive or malignant results
by IOTA simple rules are presented in Fig. 1d. We ob-
served an area under ROC curves of 0.82 (95 % CI: 0.70-
0.94) for VI, 0.67 (95 % CI: 0.50-0.84) for FI and 0.81 (95 %
CI: 0.69-0.93) for VFI. The highest cut-offs still resulting in
100 % sensitivity for malignancy were: VI ≥ 3.4, FI ≥ 31.2
and VFI ≥ 1.6. The number of false positives was 14 for all
3D-PD indices.
Among the 49 cases with malignant or inconclusive
results according to IOTA classification, 12 (24.5 %) pre-
sented vascular score two using conventional power
Doppler, 21 (42.9 %) presented vascular score 3 and 16
(32.6 %) presented vascular score 4. The distribution of
values for the 3D-PD indices according to conventional
vascular scores is represented in Fig. 2. The median of
VI was 5.0 for tumors with vascular score 2, 15.4 tumors
with vascular score 3, and 22.8 for tumors with vascular
score four (Kruskal-Wallis test, P = 0.0001). The median
of FI was 40.3 for tumors with vascular score 2, 47.3 tu-
mors with vascular score 3, and 48.0 for tumors withFig. 2 Distribution of 3D-PD indices according to power Doppler vascular sco
index (VFI)vascular score 4 (Kruskal-Wallis test, P = 0.06). The me-
dian of VFI was 2.0 for tumors with vascular score 2, 6.6
tumors with vascular score 3, and 10.4 tumors with vas-
cular score 4 (Kruskal-Wallis test, P = 0.0001).
Based on the combination of limits of agreement and
ROC curves, the sensitivity of 3D-PD presented consider-
able variation. Intra-observer variability can be reduced
the sensitivity for VI from 100 % to 75 %, for FI from
100 % to 43 % for FI and from 100 % to 64 % for VFI.
Discussion
Benign ovarian tumors can be safely managed by general
gynecologists; however malignant ovarian tumors should
be referred to a gynecologic oncology expert. The best
management of “inconclusive” cases is still not defined;
frequently the patients are referred to a gynecologic on-
cology expert and submitted to surgery. The major prob-
lem in the management of adnexal masses is to reduce
the false positive rate without reducing the sensitivity.
Our results show that 3D-PD angiography from the most
complex area of adnexal mass can distinguish benign from
malignant ovarian tumors. However, this method is not
able to reduce the false positive rates of IOTA simple
rules. The intra examiner repeatability is lower than the
minimum recomended for secure clinical use and may im-
pair significantly the accuracy of this method.
VI and VFI were more accurate to differentiate be-
tween benign and malignant ovarian tumors than FI.
However, both indices were strongly associated with con-
ventional power Doppler vascular scores. The variableres. a vascularization index (VI), b flow index (FI), c vascularization-flow
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rules classification. Therefore, this association may be an-
other reason why 3D-PD indices do not improve the ac-
curacy of IOTA classification of ovarian tumors.
Despite the relatively small sample size, our study has
the advantages of a planned prospective design and data
collection by an experienced sonographer using a single
machine with all set up parameters kept constant. Our
observed values of 3D-PD indices were higher in malig-
nant ovarian tumors which are in agreement with most
of previously published data [23]. The effect of intra-
observer variability of 3D-PD indices can be observed
considering together the limits of agreement and the
cut-offs from ROC curves. The sensitivity of the method
can vary from 100 % to 43 % due to intra-observer
variability, which in unacceptable for this group of pa-
tients. Some authors claim to have better reproducibil-
ity than we found in this series. Previous studies have
shown intra-observer intraclass correlation coefficients
(ICC) between 0.95-0.99 [9, 24, 25]. However, all these
studies were based on single 3D-PD data-sets, which
did not account for inherent clinical relevant sources of
variability caused by respiratory and intestinal move-
ments, and also from the phase of the cardiac cycle
during acquisition [26].
The prevalence of malignant cases in our sample was
high. In ultrasound settings linked to a gynecological on-
cology service the expected prevalence of malignancy in
adnexal masses is higher than in general hospitals. Among
our cases, 43 % were malignant, this prevalence is similar
to the reported prevalence of 42 % of malignancy in oncol-
ogy centers and 17 % in other centers [27].
Ovarian neoplasms are heterogeneous in morphology
and even in genetic sub-clones of malignant cells [28].
Variable patterns of vascularization are frequently identi-
fied in different portions of the same tumor [29]. There-
fore, diagnostic methods based on the analysis of parts of
the tumor produce inevitable intra-observer variability.
The key question is whether the disagreement is enough
to cause confusion and impair the method validity.
Conclusion
Our data provide strong evidence that 3D-PD angiog-
raphy from spherical biopsy is not accurate for reducing
the false positive rates of IOTA single rules.
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